Javascript must be enabled to continue!
NITAZOXANIDE IN TREATMENT OF ROTAVIRUS DIARRHEA IN CHILDREN: A SINGLE CENTER STUDY
View through CrossRef
BACKGROUND & OBJECTIVE: As Rota virus leads to significant morbidity in children 2 months to 5 years, this study was done to observe the effect of one dose of nitazoxanide on the total duration of rotavirus diarrhea. The primary objective was to evaluate the reduction in the mean duration of viral diarrhea in children after administration of first dose of Nitazoxanide.
METHODLOGY: This descriptive study was done in the Department of Pediatric Medicine Unit I, Mayo Hospital, Lahore from Jan 2016 to June 2016 after approval from the ethical review committee. Sample size calculated was 175 using WHO sample size calculator. Patients of 4–5 years were given 200 mg nitazoxanide twice daily for 3 days; 100 mg nitazoxanide was given twice daily to 12–47 months age group, and patient of <12 months age were given 7.5 mg/kg twice day along with routine care and were followed 12 hourly till the passage of normally formed stools. Duration of diarrhea was recorded.
RESULTS: Out of 175 cases, 58.9% (n=103) were between 2-36 months age while 41.2% (n=72) were 37-60 months age, mean+SD was calculated as 35.06+13.34 months, mean reduction in duration of rotavirus diarrhea in children after administration of first dose of Nitazoxanide was recorded as 32.85+2.32 hours.
CONCLUSION: With the use of nitazoxanide along with routine care for rotavirus diarrhea children, the mean duration of rotavirus diarrhea was reported to be less than 1.5 days.
University Medical and Dental College Faisalabad
Title: NITAZOXANIDE IN TREATMENT OF ROTAVIRUS DIARRHEA IN CHILDREN: A SINGLE CENTER STUDY
Description:
BACKGROUND & OBJECTIVE: As Rota virus leads to significant morbidity in children 2 months to 5 years, this study was done to observe the effect of one dose of nitazoxanide on the total duration of rotavirus diarrhea.
The primary objective was to evaluate the reduction in the mean duration of viral diarrhea in children after administration of first dose of Nitazoxanide.
METHODLOGY: This descriptive study was done in the Department of Pediatric Medicine Unit I, Mayo Hospital, Lahore from Jan 2016 to June 2016 after approval from the ethical review committee.
Sample size calculated was 175 using WHO sample size calculator.
Patients of 4–5 years were given 200 mg nitazoxanide twice daily for 3 days; 100 mg nitazoxanide was given twice daily to 12–47 months age group, and patient of <12 months age were given 7.
5 mg/kg twice day along with routine care and were followed 12 hourly till the passage of normally formed stools.
Duration of diarrhea was recorded.
RESULTS: Out of 175 cases, 58.
9% (n=103) were between 2-36 months age while 41.
2% (n=72) were 37-60 months age, mean+SD was calculated as 35.
06+13.
34 months, mean reduction in duration of rotavirus diarrhea in children after administration of first dose of Nitazoxanide was recorded as 32.
85+2.
32 hours.
CONCLUSION: With the use of nitazoxanide along with routine care for rotavirus diarrhea children, the mean duration of rotavirus diarrhea was reported to be less than 1.
5 days.
Related Results
Immunological and molecular detection of rotavirus genotype in children with gastroenteritis in Diyala-Iraq
Immunological and molecular detection of rotavirus genotype in children with gastroenteritis in Diyala-Iraq
Aim: To explore the prevalence along with the molecular detection and genotyping of group A rotavirus (RVA) among children up to 5 years old complaining of gastroenteritis in Diyal...
To compare the efficacy of 3 days treatment with Nitazoxanide vs 5 days treatment with Metronidazole in treating children with diarrhea caused by Giardia-lamblia.
To compare the efficacy of 3 days treatment with Nitazoxanide vs 5 days treatment with Metronidazole in treating children with diarrhea caused by Giardia-lamblia.
Objective: To compare the efficacy of 3 days treatment with Nitazoxanide vs 5 days treatment with Metronidazole in treating children with diarrhea caused by Giardia-lamblia. Study ...
Incidence of Rotavirus and Adenovirus Infection among Under-2 Children with Acute Watery Diarrhoea at a Tertiary Care Hospital
Incidence of Rotavirus and Adenovirus Infection among Under-2 Children with Acute Watery Diarrhoea at a Tertiary Care Hospital
Background: Diarrhea is a leading cause of childhood death in the world, account ing for 5-10 million deaths per year. Worldwide, rotavirus is estimated to cause more than 111 mill...
Prevalence and clinical profile of rotavirus in children ? 5 years admitted in a tertiary care Hospital in Western Maharashtra
Prevalence and clinical profile of rotavirus in children ? 5 years admitted in a tertiary care Hospital in Western Maharashtra
Background: Diarrhea is the second leading cause of mortality in children less than 5 years. Rotavirus is the commonest pathogen which causes diarrhea in children. As a result of d...
Determinants of Rotavirus among diarrheal children (0-5yrs) attending some health facilities in Sokoto Town, Nigeria
Determinants of Rotavirus among diarrheal children (0-5yrs) attending some health facilities in Sokoto Town, Nigeria
This study was carried out to molecularly detect and characterize Rotaviruses from children attending selected hospitals in Sokoto State. A total of 350 stools were collected from ...
Potential Impact and Cost-Effectiveness of Rotavirus Vaccination in Afghanistan (Preprint)
Potential Impact and Cost-Effectiveness of Rotavirus Vaccination in Afghanistan (Preprint)
BACKGROUND
Despite progress made in child survival in the past 20 years, 5.9 million children under five years died in 2015, with 9% of these deaths due to ...
Detection of Cryptosporidium spp. Co-infection with Rotavirus in Children Under Five Years with Diarrhea
Detection of Cryptosporidium spp. Co-infection with Rotavirus in Children Under Five Years with Diarrhea
Background: Cryptosporidium spp. and Rotavirus are recognized as important causes of acute gastroenteritis in children worldwide.
Objective: To determine the frequency of Cryptosp...
Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection. A rapid and living systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection. A rapid and living systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
Introduction Nitazoxanide is a broad-spectrum antiparasitic that has
been tested for COVID-19 due to the anti-inflammatory effects and in
vitro anti-viral activity and promising cl...

